ArticleOncology letters2019

Epigenetic treatment-mediated modulation of PD-L1 predicts potential therapy resistance over response markers in myeloid malignancies: A molecular mechanism involving effectors of PD-L1 reverse signaling.

Hongbin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.